FDA pinpoints contaminant in Baxter’s heparin
WASHINGTON (Reuters) – U.S. health regulators said on Wednesday they have identified a contaminant found in batches of Baxter International Inc's blood-thinner heparin that were linked to serious reactions and deaths.
Food and Drug Administration officials said they are trying to determine whether the chemical — over-sulfated chondroitin sulfate — was purposely or inadvertently added during manufacturing in China.
By Lisa Richwine
19 March 2008